FDA 510(k) clearance for microINR
71st AACC Annual Scientific Meeting Press ProgramiLine Microsystems announces FDA 510(k) clearance for microINR System, a Point-of-Care device for oral anticoagulation monitoring
iLine Microsystems announces FDA 510(k) clearance for microINR System, a Point-of-Care device for oral anticoagulation monitoring
Our extensive consulting and in-depth analysis has helped many clients to automate their Advanced Laboratory Information Management System Software.
Iwaki America is proud to introduce the APN-S041.
Designed with HIPPA regulations as a strict guiding principle to integrate with EMRs, EHRs, Analyzers, CRMs, and more to increase efficiency, minimize human error, and protect transmitted patient information.
VALIDATE® Heparin, for Siemens Sysmex analyzers, addresses the growing demand by laboratories in need of a product to document Heparin Anti-Xa linearity and calibration verification.
LGC Maine Standards announces VALIDATE® hsTnT kit for easier linearity and calibration verification on Roche cobas®analyzers VALIDATE® hsTnT, for Roche cobas®, is the only linearity and calibration verification product specifically targeting Roche’s Troponin T Gen 5 STAT (TnTG5) assay range.
Accuracy and precision is paramount in any scientific research, especially when the research is being carried out at microscopic level.
CINCINNATI, OHIO June 3, 2019 (GLOBE NEWSWIRE) Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced it has completed its previously announced acquisition of the business of GenePOC Inc., a Quebec City, Quebec, Canada based provider of molecular diagnostic instruments and assays.
Syracuse, N.Y. May 20, 2019 – JADAK, a business unit of Novanta Corporation (“Novanta”) announces the release of the Allegro In-Vitro Diagnostic 6MP Smart Camera, a machine vision camera designed specifically to complete standard pre-analytical IVD tasks on a rack of vials. The Allegro IVD 6MP Smart Camera, along with Clarity 3.0 software, can accurately and precisely detect and screen diagnostic samples in a timely manner, thus eliminating waste by conducting tests on incomplete samples and reducing errors typically caused by manual processes.
LGC Maine Standards announces addition of Cerebrospinal Fluid Total Protein to VALIDATE® Body Fluids kit, enhancing the only comprehensive body fluids kit on the market, for easier Laboratory Developed Test (LDT) validation, documentation of linearity and calibration verification, and reportable range verification.
LIS365 Customer Engagement has Comprehensive Features Stand out to meet the demands of unique lab environments which includes:
KNF introduces new micro gas pump NMP830 HP for OEM customers. This new diaphragm pump offers outstanding high flow, pressure, and suction performance in a compact size. It is ideal for medical therapy and monitoring applications.
VALIDATE® IBC, for Ortho VITROS® analyzers, addresses the growing demand by laboratories in need of a product to document Iron Binding Capacity linearity and calibration verification.
Introducing New 5-part hematology analyzer from Boule Diagnostics
The Clippard NIV Series Media Isolation Valve is a solenoid-operated device that uses a flexible diaphragm to isolate the actuation mechanism from the fluid path.
For many, many years, Medonic™ 3-part hematology system from Boule has provided reliable complete blood counts to hospitals, clinics, laboratories, and companies all around the world.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Bio-Rad’s IH-500, an automated random access system for blood typing and screening.
Simi Valley, CA, 18th March, 2019 – Andwin Scientific announces the official opening of its new headquarters and operational center in Los Angeles.
Cincinnati, Ohio – The Clippard NPV Series Miniature Pinch Valves are solenoid-operated devicec that is designed to open and close tubes for controlling flow of liquids and gases.
GeneReach is pleased to announce that POCKIT Central C. difficile, a cost-effective sample-to-answer PCR assay intended to aid in the diagnosis of C. difficile infection, has received CE marking.
The Loop-Mediated Isothermal Amplification, called LAMP, is a unique, temperature- independent technique for amplifying DNA. HUMAN and Eiken developed with their TB-LAMP solution this molecular method for the detection of Mycobacterium Tuberculosis Complex.
On stand 1491, Carville will be showing the latest technology in diffusion bonded, multi-layer plastic fluidic manifolds including microfluidics.
Clippard’s DVP series proportional solenoid valves are precision-built 2-way control valves, utilizing a unique, patented valving principle.
Precise, linear pressure control within a closed-loop system with ultra high resolution and repeatability.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance.
If you think that photometers have been around for a long time and no improvements are possible any more – You are wrong! Developing a new photometer from the scratch while implementing state-of-the-art information technology, HUMAN has been rethinking photometers. Special focus has been put to serve laboratories in developing and emerging countries.
AB Medical will be participating the AACC taking place on August 4-8, 2019 in Anaheim, CA USA.
Aim Lab Automation Technologies Tube Sealer Module (TSM) is specifically designed to automatically foil seal the contents of plastic sample tubes in readiness for storage or transportation. The TSM is compact in size, fully electric and generates no waste.
Veravas product launch announcement highlighting their solutions for managing biotin interference and improving future diagnostic assays.
Today, the Newborn Screening Saves Lives Reauthorization Act of 2019 was introduced in the U.S. House of Representatives by Reps. Lucille Roybal-Allard, D-Calif., and Michael Simpson, R-Idaho. This bipartisan bill is also expected to be introduced in the Senate soon. AACC commends the two legislators for introducing this bill and urges Congress to pass this legislation to ensure the continuation of pediatric testing programs that help thousands of infants receive life-saving treatments every year.
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce the recipients of the 2019 AACC and AACC Academy Awards. Through this annual awards program, AACC and its academy strive to recognize laboratory medicine professionals in all stages of their careers and to build public awareness that clinical laboratory testing plays a critical role in improving patient health.
In a letter to the Senate and House Appropriations Subcommittees on Labor, Health and Human Services, Education, and Related Agencies, AACC and 19 other major healthcare organizations urged Congress to provide funding so that the Centers for Disease Control and Prevention (CDC) can fill a crucial gap in children’s medical testing by developing accurate pediatric reference intervals.
New findings, published today in AACC’s Clinical Chemistry journal, add to a growing body of evidence suggesting that no legal driving limit for cannabis can catch impaired recreational users without unfairly penalizing unimpaired regular or medicinal users.
Healthcare providers depend on lab test results to help them diagnose and determine the most effective treatments for children—especially when treating children who are too young to communicate their symptoms. Join AACC and leading experts in laboratory medicine for a discussion about the need to develop precise pediatric reference intervals to improve lab testing for children, and the challenges that must be overcome before this can be accomplished.
In this special Sepsis Issue, AACC’s The Journal of Applied Laboratory Medicine highlights the cutting-edge clinical tests that laboratory medicine experts are developing to combat sepsis, a life-threatening condition that kills more people in the U.S. than heart attacks every year.
A first-of-its-kind study indicates that male partners of women with recurrent pregnancy loss have reduced sperm quality caused by impaired reproductive hormone production and high oxidant levels. This research, published in the Men’s Health Issue of AACC’s Clinical Chemistry journal, could help more couples with recurrent pregnancy loss to conceive by leading to new treatments that improve male partners’ reproductive health.
Novel studies published in the Men’s Health Issue of AACC’s journal Clinical Chemistry suggest that hormone therapy for transgender people increases the risk of blood clots less than birth control pills and does not increase the risk of cardiovascular disease at all. These preliminary results could help more transgender individuals to access essential hormone therapy by increasing physician comfort with prescribing it.
In a special Men’s Health Issue, AACC’s Clinical Chemistry journal spotlights breaking research that is crucial for men—and for patient populations with which men’s health isn’t historically associated, from transgender individuals to pregnant women. This issue aims not only to address men’s unmet health needs, but also to reduce health disparities by promoting dialogue between the men’s, women’s, and transgender health fields.
On Thursday, December 6, House and Senate lawmakers released bipartisan draft legislation, known as the Verifying Accurate, Leading-edge In Vitro Clinical Test Development (VALID) Act, which outlines a framework for the Food and Drug Administration (FDA) to regulate laboratory developed tests. AACC will oppose this bill if, as in previous iterations, it promotes additional, duplicative, costly federal regulations for clinical laboratories that will result in decreased patient access to essential medical tests.
With more and more medical tests being performed outside the traditional clinical laboratory, AACC released a position statement today emphasizing the need to ensure consistent high-quality testing at non-traditional facilities such as physician offices and pharmacies. The statement urges Congress to direct the Department of Health and Human Services (HHS) to study testing at non-traditional sites and to recommend steps to ensure patients get consistently reliable results to facilitate effective treatment.
Researchers have developed a new test that could diagnose chronic kidney disease early in patients with type 2 diabetes. This novel method, published today in AACC’s Clinical Chemistry journal, could improve quality of life for diabetic patients by potentially catching chronic kidney disease in time to stop its progression to full-blown kidney failure.
AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce that David G. Grenache, PhD, DABCC, MT(ASCP), FAACC, has been elected to serve on the AACC Board of Directors as president-elect starting in January 2019. Following this, he will serve successive terms as the association’s president from August 2020-July 2021 and as past president from August 2021-July 2022. In addition, the AACC membership elected a new treasurer and two new directors to the association’s Board. They will take office at the start of 2019 along with the incoming president of AACC Academy, who will also serve on the Board.
AACC welcomed thousands of medical professionals and healthcare leaders at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo from July 29–August 2. The meeting showcased advancements in clinical testing technology and research that improve the ability of healthcare providers to diagnose patients quickly and accurately and ensure that patients get effective medical treatment.
Announcement of a New IFCC Division
Introduction to Traceability in laboratory medicine (TLM) and Joint IFCC and JCTLM initiatives in this area
Announcement of next IFCC EuroMedLab and WorldLab Congresses
IMV, part of the Science and Medicine Group, the leading market research and business intelligence provider to the laboratory diagnostic industry, announced the category winners of the 2018 IMV ServiceTrak™ awards in clinical analyzers. Sysmex America, Inc. was recognized for: Hematology: •Best System Performance •Best Customer Satisfaction •Best Service
Novel findings unveiled at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo show that gender-affirming hormone therapy markedly impacts the results of common laboratory tests for transgender patients. This study underscores the need for transgender-specific reference intervals to ensure this underserved population receives accurate diagnoses and effective treatments.
AACC announced today the launch of a new credential for point-of-care testing professionals. This new certification – the first of its kind in the United States -- is designed for healthcare experts who perform diagnostic tests outside the central laboratory.
For decades, microbiologists have done their work by hand even as robotics and automation began to improve other laboratory processes. Until recently, the delicate techniques necessary to introduce mechanisms to microorganism study and analysis have been challenging for these divisions to automate. Now that's changing.